Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics.
Fokam J, Nka AD, Mamgue Dzukam FY, Efakika Gabisa J, Bouba Y, Tommo Tchouaket MC, Ka'e AC, Ngoufack Jagni Semengue E, Takou D, Moudourou S, Fainguem N, Pabo W, Nayang Mundo RA, Kengni Ngueko AM, Ambe Chenwi C, Flore Yimga J, Nnomo Zam MK, Simo Kamgaing R, Tangimpundu C, Kamgaing N, Njom-Nlend AE, Ndombo Koki P, Kesseng D, Ndiang Tetang S, Kembou E, Ebiama Lifanda L, Pamen B, Ketchaji A, Saounde Temgoua E, Billong SC, Zoung-Kanyi Bissek AC, Hadja H, Halle EG, Colizzi V, Perno CF, Sosso SM, Ndjolo A.
Fokam J, et al. Among authors: colizzi v.
Medicine (Baltimore). 2023 May 19;102(20):e33737. doi: 10.1097/MD.0000000000033737.
Medicine (Baltimore). 2023.
PMID: 37335723
Free PMC article.